Medpace Holdings, Inc. MEDP Balance Sheet

Medpace holdings, inc. (MEDP)

Balance Sheet / TTM

Mar'20	Dec'19	Sep'19	Jun'19	Mar'19	Dec'18	Sep'18	Jun'18	Mar'18	Dec'17	Sep'17	Jun'17	Mar'17	Dec'16	Sep'16	Dec'15
ASSETS
Current assets:
Cash and cash equivalents
133,999	131,920	79,290	20,098	30,127	23,275	22,244	22,230	22,245	26,485	24,168	29,055	29,316	37,099	14,636	14,880
Restricted cash
-	-	0	0	0	7	7	7	7	7	79	275	293	308	3,363	2,857
Accounts receivable and unbilled, net (includes $2.8 million and $1.9 million with related parties at March 31, 2020 and December 31, 2019, respectively)
136,374	155,662	140,189	149,860	129,624	133,449	108,285	115,398	110,654	83,079	74,708	76,664	82,283	79,767	81,922	65,088
Prepaid expenses and other current assets
32,629	29,446	30,918	24,386	22,624	21,383	22,549	20,844	20,848	20,400	18,074	17,129	16,433	16,074	20,606	11,896
Total current assets
303,002	317,028	250,397	194,344	182,375	178,114	153,085	158,479	153,754	129,971	117,029	123,123	128,325	133,248	120,527	94,721
Property and equipment, net
50,015	47,292	43,715	39,749	37,639	52,255	52,030	52,360	51,079	48,739	45,903	45,244	44,976	43,805	41,342	37,512
Operating lease right-of-use assets
58,667	52,152	52,479	51,809	53,627	0	-	-	-	-	-	-	-	-	-	-
Goodwill
662,427	662,396	662,427	662,427	662,380	660,981	660,981	660,981	660,981	660,981	660,981	660,981	660,981	660,981	660,981	660,981
Intangible assets, net
52,353	54,350	57,345	60,340	63,335	69,179	76,569	83,959	91,349	98,740	108,234	117,676	126,623	136,071	148,739	186,743
Deferred income taxes
490	376	293	313	330	713	446	5,972	9,970	6,343	11,115	11,536	154	97	135	157
Other assets
10,680	9,477	5,673	7,879	6,831	6,691	6,732	6,430	5,891	5,943	5,614	5,086	5,034	4,903	4,763	3,927
Total assets
1,137,634	1,143,071	1,072,329	1,016,861	1,006,517	967,933	949,843	968,181	973,024	950,717	948,876	963,646	966,093	979,105	976,487	984,041
LIABILITIES AND SHAREHOLDERS’ EQUITY
Current liabilities:
Accounts payable (includes $0.1 million and $0.2 million with related parties at March 31, 2020 and December 31, 2019, respectively)
16,985	22,404	20,684	22,691	13,626	16,737	13,602	16,859	17,924	16,674	9,972	7,195	8,345	10,911	9,337	8,728
Accrued expenses
107,005	109,252	102,535	93,604	82,247	87,493	80,328	72,925	63,576	23,673	20,085	16,392	14,083	24,417	21,415	20,111
Pre-funded study costs (includes $1.0 million with related parties at December 31, 2017)
-	-	-	-	-	-	0	0	0	57,406	53,246	48,530	48,473	51,948	53,418	46,599
Advanced billings (includes $1.1 million and $3.0 million with related parties at March 31, 2020 and December 31, 2019, respectively)
189,562	192,359	169,500	165,400	150,200	147,900	133,403	120,945	126,387	73,756	68,341	65,577	60,474	65,668	67,662	51,051
Current portion of long-term debt
-	-	-	-	-	-	0	16,500	16,500	16,500	15,469	14,438	13,406	12,375	-	59
Other current liabilities
25,099	18,987	21,644	14,331	18,425	4,861	4,794	5,933	8,105	4,697	5,250	3,130	5,264	3,284	4,763	7,469
Total current liabilities
338,651	343,002	314,392	296,073	264,541	257,026	232,127	233,162	232,492	192,706	172,363	155,262	150,045	168,603	156,595	134,017
Long-term debt, net, less current portion
-	-	0	0	55,781	79,721	113,689	147,021	181,067	205,111	169,152	143,191	147,230	151,267	154,614	377,882
Operating lease liabilities
51,395	45,212	46,022	43,731	46,238	0	-	-	-	-	-	-	-	-	-	-
Deemed landlord liability, less current portion
-	-	0	0	0	24,484	25,035	25,571	26,091	26,602	27,104	27,591	28,063	28,527	28,983	30,273
Deferred income tax liability
14,022	12,849	5,578	4,599	3,435	439	2,636	602	596	560	513	481	11,683	12,030	20,506	21,104
Deferred credit
-	-	-	-	-	-	3,953	11,061	11,265	11,468	20,956	21,420	-	0	-	-
Other long-term liabilities
15,767	15,725	14,330	14,403	14,625	16,560	11,014	10,683	10,440	10,740	8,538	8,343	8,092	7,968	5,249	7,291
Total liabilities
419,835	416,788	380,322	358,806	384,620	378,230	388,454	428,100	461,951	447,187	398,626	356,288	345,113	368,395	365,947	570,567
Commitments and contingencies (see Note 11)
-	-	-	-	-	-	0	0	0	-	0	0	0	0	0	0
Shareholders’ equity:
Preferred stock - $0.01 par-value; 5,000,000 shares authorized; no shares issued and outstanding at March 31, 2020 and December 31, 2019, respectively
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Common stock - $0.01 par-value; 250,000,000 shares authorized at March 31, 2020 and December 31, 2019, respectively; 35,484,473 and 36,065,278 shares issued and outstanding at March 31, 2020 and December 31, 2019, respectively
355	360	360	359	357	356	356	356	355	355	375	398	407	407	407	326
Treasury stock - 200,000 shares at March 31, 2020 and December 31, 2019, respectively
6,030	6,030	6,030	6,030	6,030	6,030	6,030	6,030	6,030	6,030	-	-	-	0	-	-
Additional paid-in capital
673,372	666,585	663,044	651,784	643,497	639,381	636,536	634,469	632,374	630,341	628,558	627,407	625,296	623,629	622,071	438,716
Retained earnings
53,831	68,109	38,296	14,319	-13,136	-41,487	-67,294	-86,599	-115,521	-120,402	-77,420	-18,419	-1,577	-9,584	-9,563	-23,009
Accumulated other comprehensive loss
-3,729	-2,741	-3,663	-2,377	-2,791	-2,517	-2,179	-2,115	-105	-734	-1,263	-2,028	-3,146	-3,742	-2,375	-2,559
Total shareholders’ equity
717,799	726,283	692,007	658,055	621,897	589,703	561,389	540,081	511,073	503,530	550,250	607,358	620,980	610,710	610,540	413,474
Total liabilities and shareholders’ equity
1,137,634	1,143,071	1,072,329	1,016,861	1,006,517	967,933	949,843	968,181	973,024	950,717	948,876	963,646	966,093	979,105	976,487	984,041